B. E. Serjeant

3.4k total citations · 1 hit paper
60 papers, 2.5k citations indexed

About

B. E. Serjeant is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, B. E. Serjeant has authored 60 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Genetics, 48 papers in Hematology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in B. E. Serjeant's work include Hemoglobinopathies and Related Disorders (56 papers), Iron Metabolism and Disorders (42 papers) and Blood groups and transfusion (25 papers). B. E. Serjeant is often cited by papers focused on Hemoglobinopathies and Related Disorders (56 papers), Iron Metabolism and Disorders (42 papers) and Blood groups and transfusion (25 papers). B. E. Serjeant collaborates with scholars based in Jamaica, United Kingdom and Germany. B. E. Serjeant's co-authors include G. R. Serjeant, Peter Thomas, Karlene Mason, J Morris, J Pattison, G Char, Paul Milner, B. Balkaran, J M Topley and Rosmawati Mohamed and has published in prestigious journals such as The Lancet, Blood and The Journal of Pediatrics.

In The Last Decade

B. E. Serjeant

59 papers receiving 2.3k citations

Hit Papers

OUTBREAK OF APLASTIC CRISES IN SICKLE CELL ANAEMIA ASSOCI... 1981 2026 1996 2011 1981 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. E. Serjeant Jamaica 24 2.0k 1.7k 665 467 263 60 2.5k
Jeffrey S. Lobel United States 15 935 0.5× 757 0.5× 498 0.7× 150 0.3× 72 0.3× 33 1.7k
Isabelle Thuret France 27 726 0.4× 1.2k 0.7× 596 0.9× 308 0.7× 174 0.7× 113 2.4k
G. Cornu Belgium 21 736 0.4× 873 0.5× 424 0.6× 187 0.4× 255 1.0× 60 1.9k
Campbell W. McMillan United States 22 630 0.3× 1.7k 1.0× 139 0.2× 115 0.2× 324 1.2× 54 2.4k
C. Vermylen Belgium 18 707 0.4× 741 0.4× 381 0.6× 168 0.4× 117 0.4× 56 1.4k
Laura Detti United States 19 230 0.1× 674 0.4× 1.2k 1.8× 449 1.0× 260 1.0× 80 2.0k
Malika Benkerrou France 26 666 0.3× 958 0.6× 155 0.2× 211 0.5× 235 0.9× 82 2.2k
C. Philip Steuber United States 23 331 0.2× 1.1k 0.6× 460 0.7× 97 0.2× 40 0.2× 63 2.0k
F Bonetti Italy 23 220 0.1× 761 0.5× 241 0.4× 130 0.3× 194 0.7× 74 1.7k
D Powars United States 19 861 0.4× 667 0.4× 229 0.3× 84 0.2× 123 0.5× 31 1.3k

Countries citing papers authored by B. E. Serjeant

Since Specialization
Citations

This map shows the geographic impact of B. E. Serjeant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. E. Serjeant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. E. Serjeant more than expected).

Fields of papers citing papers by B. E. Serjeant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. E. Serjeant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. E. Serjeant. The network helps show where B. E. Serjeant may publish in the future.

Co-authorship network of co-authors of B. E. Serjeant

This figure shows the co-authorship network connecting the top 25 collaborators of B. E. Serjeant. A scholar is included among the top collaborators of B. E. Serjeant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. E. Serjeant. B. E. Serjeant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Serjeant, G. R., B. E. Serjeant, Karlene Mason, et al.. (2022). The haematology of Jamaicans: red cell indices in HbAA, HbAS, HbAC, and HbA-HPFH genotypes. Journal of Community Genetics. 13(2). 229–234. 2 indexed citations
2.
Serjeant, G. R., et al.. (2017). Voluntary premarital screening to prevent sickle cell disease in Jamaica: does it work?. Journal of Community Genetics. 8(2). 133–139. 19 indexed citations
3.
Mason, Karlene, F. D. Gibson, Ian Hambleton, B. E. Serjeant, & G. R. Serjeant. (2015). Iron Deficiency among Jamaican Adolescents. West Indian Medical Journal. 63(6). 561–5. 3 indexed citations
4.
Mason, Karlene, F. D. Gibson, Lorraine Warren, et al.. (2015). Newborn Screening for Sickle Cell Disease: Jamaican Experience. West Indian Medical Journal. 65(1). 18–26. 3 indexed citations
5.
Serjeant, G. R., et al.. (2008). The changing face of homozygous sickle cell disease: 102 patients over 60 years. International Journal of Laboratory Hematology. 31(6). 585–596. 32 indexed citations
6.
Hambleton, Ian, et al.. (2004). Newborn screening for sickle cell disease in Brazil: the Campinas experience. Clinical & Laboratory Haematology. 26(1). 15–19. 28 indexed citations
7.
Donaldson, Alan, Peter Thomas, B. E. Serjeant, & G. R. Serjeant. (2001). Foetal haemoglobin in homozygous sickle cell disease: a study of patients with low HBF levels*. Clinical & Laboratory Haematology. 23(5). 285–289. 15 indexed citations
8.
Serjeant, B. E., et al.. (1997). Microchromatographic quantitation of gemoglobin A levels in phenotypes of sickle cell-beta+ thalassemia. Journal of Chromatography B Biomedical Sciences and Applications. 700(1-2). 269–274. 4 indexed citations
9.
Lee, Alvin, et al.. (1995). Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ. 311(7020). 1600–1602. 155 indexed citations
10.
Serjeant, G. R., B. E. Serjeant, Peter Thomas, et al.. (1993). Human parvovirus infection in homozygous sickle cell disease. The Lancet. 341(8855). 1237–1240. 102 indexed citations
11.
Singhal, Ash, Peter Thomas, B. E. Serjeant, et al.. (1993). Is there an acute-phase response in steady-state sickle cell disease?. The Lancet. 341(8846). 651–653. 62 indexed citations
12.
Balkaran, B., G Char, J Morris, et al.. (1992). Stroke in a cohort of patients with homozygous sickle cell disease. The Journal of Pediatrics. 120(3). 360–366. 326 indexed citations
13.
Christakis, John, N. Vavatsi, Maria Papadopoulou, et al.. (1991). A comparison of sickle cell syndromes in Northern Greece. British Journal of Haematology. 77(3). 386–391. 20 indexed citations
14.
Sackey, Kwesi, George T. Roberts, Andreas E. Kulozik, et al.. (1991). Two different forms of homozygous sickle cell disease occur in Saudi Arabia. British Journal of Haematology. 79(1). 93–98. 116 indexed citations
15.
Christakis, John, Maria Papadopoulou, K. Mandraveli, et al.. (1990). Comparison of homozygous sickle cell disease in Northern Greece and Jamaica. The Lancet. 335(8690). 637–640. 30 indexed citations
16.
Murray, Neil A, B. E. Serjeant, & G. R. Serjeant. (1988). Sickle cell‐hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes. British Journal of Haematology. 69(1). 89–92. 29 indexed citations
17.
Vyas, Paresh, Douglas R. Higgs, D. J. Weatherall, et al.. (1988). The interaction of alpha thalassaemia and sickle cell–beta° thalassaemia. British Journal of Haematology. 70(4). 449–454. 9 indexed citations
18.
Maude, G. H., Douglas R. Higgs, Yvonne Grandison, et al.. (1985). Alpha thalassaemia and the haematology of normal Jamaican children. Clinical & Laboratory Haematology. 7(4). 289–295. 10 indexed citations
19.
Serjeant, B. E., Karlene Mason, P I Condon, et al.. (1984). Blood rheology and proliferative retinopathy in sickle cell-haemoglobin C disease.. British Journal of Ophthalmology. 68(5). 325–328. 13 indexed citations
20.
Serjeant, G. R., B. E. Serjeant, & Paul Milner. (1969). The Irreversibly Sickled Cell; a Determinant of Haemolysis in Sickle Cell Anaemia. British Journal of Haematology. 17(6). 527–533. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026